Bimal Bhindi1, Christine M Lohse2, Phillip J Schulte2, Ross J Mason3, John C Cheville4, Stephen A Boorjian3, Bradley C Leibovich3, R Houston Thompson5. 1. Department of Urology, Mayo Clinic, Rochester, MN, USA; Southern Alberta Institute of Urology, Calgary, Alberta, Canada. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 3. Department of Urology, Mayo Clinic, Rochester, MN, USA. 4. Department of Pathology, Mayo Clinic, Rochester, MN, USA. 5. Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: Thompson.Robert@mayo.edu.
Abstract
BACKGROUND: Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit. OBJECTIVE: To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30d following PN and RN, separately. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15ml/min/1.73m2. INTERVENTION: RN and PN. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal RGLMM2, which ranges from 0 to 1, with higher values indicating increased predictive ability. RESULTS AND LIMITATIONS: The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66ml/min/1.73m2 (standard deviation [SD]=18) and 72ml/min/1.73m2 (SD=20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal RGLMM2=0.41). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal RGLMM2). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts. CONCLUSIONS: We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making. PATIENT SUMMARY: We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors.
BACKGROUND: Partial nephrectomy (PN) is generally favored for cT1tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit. OBJECTIVE: To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30d following PN and RN, separately. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15ml/min/1.73m2. INTERVENTION: RN and PN. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal RGLMM2, which ranges from 0 to 1, with higher values indicating increased predictive ability. RESULTS AND LIMITATIONS: The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66ml/min/1.73m2 (standard deviation [SD]=18) and 72ml/min/1.73m2 (SD=20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal RGLMM2=0.41). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal RGLMM2). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts. CONCLUSIONS: We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making. PATIENT SUMMARY: We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors.
Authors: Andrew G McIntosh; Daniel C Parker; Brian L Egleston; Robert G Uzzo; Mohammed Haseebuddin; Shreyas S Joshi; Rosalia Viterbo; Richard E Greenberg; David Y T Chen; Marc C Smaldone; Alexander Kutikov Journal: BJU Int Date: 2019-06-30 Impact factor: 5.588
Authors: Patrick O Richard; Philippe D Violette; Bimal Bhindi; Rodney H Breau; Wassim Kassouf; Luke T Lavallée; Michael Jewett; John R Kachura; Anil Kapoor; Maxine Noel-Lamy; Michael Ordon; Stephen E Pautler; Frédéric Pouliot; Alan I So; Ricardo A Rendon; Simon Tanguay; Christine Collins; Maryam Kandi; Bobby Shayegan; Andrew Weller; Antonio Finelli; Andrea Kokorovic; Jay Nayak Journal: Can Urol Assoc J Date: 2022-02 Impact factor: 1.862
Authors: Andrew Silagy; Emily Zabor; Roy Mano; Renzo DiNatale; Julian Marcon; Mahyar Kashani; Kyle Blum; Eduard Reznik; Edgar Jaimes; Jonathan Coleman; A Ari Hakimi; Paul Russo Journal: Can Urol Assoc J Date: 2021-02 Impact factor: 1.862
Authors: Robert J Ellis; Sharon J Del Vecchio; Kevin M J Gallagher; Danielle N Aliano; Neil Barber; Damien M Bolton; Etienne T S Chew; Jeff S Coombes; Michael D Coory; Ian D Davis; James F Donaldson; Ross S Francis; Graham G Giles; Glenda C Gobe; Carmel M Hawley; David W Johnson; Alexander Laird; Steve Leung; Manar Malki; David J T Marco; Alan S McNeill; Rachel E Neale; Keng L Ng; Simon Phipps; Grant D Stewart; Victoria M White; Simon T Wood; Susan J Jordan Journal: J Am Soc Nephrol Date: 2020-04-01 Impact factor: 10.121